VIP
Overview
Research-use neuropeptide supplied for studies of VPAC receptor signaling, neuroimmune communication, and inflammatory pathway models.
- Concentration
- 10 mg
- Stock
- In stock
Product details
VIP is a synthetic vasoactive intestinal peptide research material used in models of VPAC receptor signaling and neuroimmune communication. Pattern lists this material for controlled laboratory research.
Research Targets: VPAC1 and VPAC2 receptor signaling, cAMP pathway models, neuroimmune communication, cytokine signaling systems.
Key Feature: 28-amino-acid neuropeptide format for VPAC pathway research.
Research Focus Areas: Neuroimmune regulation, inflammatory pathway studies, pulmonary and gut signaling, vascular tone pathway models.
Common Models: Inflammatory pathway models, neurodegeneration model systems, pulmonary signaling assays, gut signaling studies.
Mechanistic Interests: cAMP signaling, cytokine balance, neuronal-immune pathway crosstalk, smooth-muscle signaling markers.
Use Boundary: Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Product documentation
Certificate of Analysis
Vasoactive Intestinal Peptide (VIP)
Review the public certificate available for this product before creating an account or checking out.
Research context
Peptide guide
Open full guide- Guide profile
- Vasoactive Intestinal Peptide
- Composition
- Naturally occurring 28-amino-acid neuropeptide hormone belonging to the secretin/glucagon superfamily, functioning as both a neurotransmitter and hormone
- Discovery
- First isolated in 1970 from porcine small intestine by Said and Mutt, initially identified for its vasodilatory properties
- Research scope
- Extensive preclinical studies demonstrate cytoprotective, anti-inflammatory, and neuroprotective effects across multiple models
- Regulatory status
- No large-scale approvals exist; lacks FDA approval for broad therapeutic use
Safety context
- Limited data; caution in hypotension
- Cardiovascular instability
- Hypersensitivity to VIP or components
Research-use notice: VIP has broad biologic effects as a vasodilator, immune-signaling peptide, and neuropeptide, but clinical evidence is small, indication-specific, and mixed. It lacks major regulatory approval for broad therapeutic use and is primarily exploratory in many contexts. Clinical decisions require qualified medical oversight, especially where cardiovascular effects matter.
Full guide includes 10 reference entries.
One kit adds 10 vials to WooCommerce checkout.